Get started
Author

David Adrian Ewald

Observed names: Adrian Ewald, D.A. Ewald, David A. Ewald, Ewald, David, Ewald, David A.
ORCID: 0000-0001-6620-2738
Observed ORCID: 0000-0001-6620-2738
OpenAlex ID: A5065178554
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
2015 · Mayte Suárez-Fariñas, Benjamin Ungar, et al. · Journal of Allergy and Clinical Immunology · 271
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
2015 · Hitokazu Esaki, David A. Ewald, et al. · Journal of Allergy and Clinical Immunology · 219
Differential bacterial capture and transport preferences facilitate co-growth on dietary xylan in the human gut
2018 · Maria Louise Leth, Morten Ejby, et al. · Nature Microbiology · 185
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · David A. Ewald, Dana Malajian, et al. · BMC Medical Genomics · 167
PDF
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
2016 · David A. Ewald, Shinji Noda, et al. · Journal of Allergy and Clinical Immunology · 114
Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
2019 · Lewis E. Tomalin, Chris B. Russell, et al. · Journal of Allergy and Clinical Immunology · 66
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
2021 · M.A.X. Tollenaere, J. Hebsgaard, et al. · British Journal of Dermatology · 61
PDF
Assessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Minipunch Biopsies
2022 · Tu Hu, Tanja Todberg, et al. · Journal of Investigative Dermatology · 23
PDF
Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment
2022 · Stefan Eirefelt, Martin Stahlhut, et al. · Scientific Reports · 11
PDF
Profiling the Atopic Dermatitis Epidermal Transcriptome by Tape Stripping and BRB-seq
2022 · Tu Hu, Tanja Todberg, et al. · International Journal of Molecular Sciences · 8
PDF
Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation Model
2021 · Paola Lovato, Li Jiang, et al. · Dermatology and Therapy · 8
PDF
Single Site Suppressors of a Fission Yeast Temperature-Sensitive Mutant in cdc48 Identified by Whole Genome Sequencing
2015 · Irina N. Marinova, Jacob Engelbrecht, et al. · PLoS ONE · 6
PDF
430 Preclinical evaluation of a novel non-steroidal glucocorticoid receptor agonist with low systemic exposure and reduced potential for skin atrophy
2017 · H. Norsgaard, M. Stahlhut, et al. · Journal of Investigative Dermatology
Additional file 18: Table E13. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 8: Table E4. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 2: Table E9. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 13: Table E8. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 5: Table E2. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 12: Table E7. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 9: Table E5. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 17: Table E12. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 7: Table E3. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 15: Table E10. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 16: Table E11. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Additional file 11: Table E6. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
2015 · Ewald, David, Malajian, Dana, et al. · Figshare
Works count: 32
Citation count: 1,139
H-index: 9
I10-index: 9
Year
Topic
Type